







How many people in each risk group.
Which viruses lead to hospital stays.
How long people stay in hospital.
What happens after they leave.
The VIVID study was designed by a team of researchers from:
The VIVID study is led by Professor Thushan de Silva at the University of Sheffield. He is also an infectious disease doctor at Sheffield Teaching Hospitals.
The University of Sheffield sponsors the study. This means it makes sure the research is safe, ethical and high quality. The VIVID study is funded by AstraZeneca. AstraZeneca has no role in the design of the study, access to data or data analysis.
The study uses existing data collected by the NHS and register offices in England.
This includes:
We will only use the parts of the data that help answer our research questions.
We will not receive doctors’ notes or any personal details.
The research team will only have access to de-identified data. This means personal details - like names and addresses - have been removed.
You can find more information in our study privacy notice.
Once the study receives final approvals, we will begin analysing the data.
We expect final results by summer 2028.
We will post regular updates on this website and welcome your feedback along the way.
No. The VIVID research team cannot see names, addresses, dates of birth, or NHS numbers. We only study de-identified data, which means personal details are removed. It is also against the law to try to identify anyone from this data.
Keeping your data safe is our top priority.
We follow the Five Safes approach:
We also follow strict UK laws and university rules to keep all data protected. You can read more about this on the Understanding Patient Data website.
The VIVID study will use some data from the UK Health Security Agency (UKHSA) and NHS England. Both these organisations hold “confidential patient information”. That is data that combines information about patients' identities and their health.
They already collect this information for their public health work.
To help the VIVID study, NHS England will securely send data to UKHSA. UKHSA will then match records belonging to the same patient from across datasets. They will do this for all patients represented in the data. This transfer and matching are the only steps that involve confidential patient information.
After the records are matched, all personal details are removed. The VIVID research team only receives this de-identified data. UKHSA then deletes data it received for use in the study.
The research team will only have access to de-identified data, so we won’t know whose records we’re looking at. But NHS England and the UK Health Security Agency will process confidential patient information on our behalf.
We requested permission to use this information without asking each person directly.
This is because:
Using confidential patient information (CPI) requires special approval:
An independent NHS Research Ethics Committee gave the study ethical approval (reference 25/LO/0589).
Even with these approvals, UKHSA and NHS England decide whether to share data. All decisions balance the potential risks and public benefits of the research.
The University of Sheffield must follow UK data protection laws at all times.
You can find more details in our study privacy notice
You can choose not to have your NHS records included in this research.
To do this, please fill in the VIVID study opt-out form.
Once the data has been de-identified, it will no longer be possible to remove your records. This is because it will not be possible to connect a record to a person.
If you have already used the NHS National Data Opt-Out, your records will not be included in this study.
We would like your views on the VIVID study, especially about using patient data.
Please share your thoughts on:
Your views will help shape how the study is designed and ensure it reflects public concerns.
Have a question or something not covered on our site? Email us at vivid@sheffield.ac.uk and we’ll get back to you as soon as we can.




